Home / Brands / Fresenius Kabi Compounding
Fresenius Kabi Compounding Recalls
15 recalls on record · October 30, 2024 to February 18, 2026 · Drugs
Recalls by year
24
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
February 18, 2026DrugsFDA
Fresenius Kabi Compounding, LLC recalls vancomycin HCl, 2 grams, 2 grams added to 500 mL, 0.9% Sodium Chloride Injection, USP, Fagron Sterile Services, 20 Dan R
Hazard: Lack of Assurance of Sterility
February 18, 2026DrugsFDA
Fresenius Kabi Compounding, LLC recalls vancomycin HCl, 1.5 grams, 1.5 grams added to 500 mL, 0.9% Sodium Chloride Injection, USP, Fagron Sterile Services, 20 D
Hazard: Lack of Assurance of Sterility
February 18, 2026DrugsFDA
Fresenius Kabi Compounding, LLC recalls thiamine HCl, 500 mg, 500 mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, Fagron Sterile Services, 20 Dan Road,
Hazard: Lack of Assurance of Sterility
February 18, 2026DrugsFDA
Fresenius Kabi Compounding, LLC recalls ketamine HCl, 1,000 mg, 1,000 mg per 100 mL (10 mg per mL) in Sodium Chloride Injection, Fagron Sterile Services, 20 Dan
Hazard: Lack of Assurance of Sterility
February 18, 2026DrugsFDA
Fresenius Kabi Compounding, LLC recalls acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Ba
Hazard: Lack of Assurance of Sterility
October 30, 2024DrugsFDA
Fresenius Kabi Compounding, LLC recalls Thiamine HCl 0.9% Sodium Chloride Injection USP, 500 mg per 100 mL, Single Dose Bag, Rx only, Fagron Sterile Services, C
Hazard: cGMP violations
October 30, 2024DrugsFDA
Fresenius Kabi Compounding, LLC recalls EPINEPHrine 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL Single Dose Bag, Rx only, Fagron Sterile Services, Canto
Hazard: cGMP violations
October 30, 2024DrugsFDA
Fresenius Kabi Compounding, LLC recalls Oxytocin 0.9% Sodium Chloride Injection USP, 30 units per 500 mL Single Dose Bag, Rx only, Fagron Sterile Services, Cant
Hazard: cGMP violations
October 30, 2024DrugsFDA
Fresenius Kabi Compounding, LLC recalls NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile
Hazard: cGMP violations
October 30, 2024DrugsFDA
Fresenius Kabi Compounding, LLC recalls NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 4 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile
Hazard: cGMP violations
October 30, 2024DrugsFDA
Fresenius Kabi Compounding, LLC recalls Vancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USP, Single Dose Bag, Rx only, Fagron Sterile Services,
Hazard: cGMP violations
October 30, 2024DrugsFDA
Fresenius Kabi Compounding, LLC recalls Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 10 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Service
Hazard: cGMP violations
October 30, 2024DrugsFDA
Fresenius Kabi Compounding, LLC recalls Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 10 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Service
Hazard: cGMP violations
October 30, 2024DrugsFDA
Fresenius Kabi Compounding, LLC recalls Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Service
Hazard: cGMP violations
October 30, 2024DrugsFDA
Fresenius Kabi Compounding, LLC recalls Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Service
Hazard: CGMP violations